Chemours
416 hedge funds and large institutions have $3.13B invested in Chemours in 2016 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 99 increasing their positions, 132 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
416
Holders Change
+39
Holders Change %
+10.34%
% of All Funds
10.42%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.15%
New
92
Increased
99
Reduced
132
Closed
47
Calls
$56.7M
Puts
$31M
Net Calls
+$25.8M
Net Calls Change
+$11.7M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$200M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$133M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$79.5M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$53.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$48.4M |
Top Sellers
| 1 |
GC
Greenlight Capital
New York
|
-$164M |
| 2 |
SC
Sessa Capital
New York
|
-$107M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
-$90M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$48.8M |
| 5 |
FCP
Fine Capital Partners
New York
|
-$32.3M |
